Overview

Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China

Status:
Recruiting
Trial end date:
2021-09-20
Target enrollment:
Participant gender:
Summary
A Prospective, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled, Trial of Ulinastatin Treatment in Adult Patients with Sepsis and Septic Shock in China
Phase:
Phase 4
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborator:
Techpool Bio-Pharma Co., Ltd.
Treatments:
Trypsin Inhibitors
Urinastatin